| Product Name | MF | CAS | Details |
|---|
| BAY-405 | C25H23F5N4O3 | 2442532-66-1 | Details |
| JNK-1-IN-4 | C22H25BrN6O3 | 3047795-60-5 | Details |
| C.I. Pigment Red 60 | C17H9N2Na3O9S2 | 1836-22-2 | Details |
| (-)-5-HT2C agonist-3 | 2104810-16-2 | Details |
| BIO399 | Details |
| Veonetinib | C27H28FN3O4 | 1210828-09-3 | Details |
| CGamF | 168912-70-7 | Details |
| ATG12-IN-1 | C23H15ClN4O2 | 2950162-68-0 | Details |
| Inosine 5′-diphosphate sodium | C10H17N4NaO12P2 | 81012-88-6 | Details |
| Advastab TM 188 | C36H72O4S2Sn | 26401-97-8 | Details |
| YM-I-26 | C28H33ClN2O5S2 | 2585015-90-1 | Details |
| Ulacamten | C21H25F2N3O3 | 2830607-59-3 | Details |
| TMV-IN-12 | C19H17N3O3 | 2861919-00-6 | Details |
| A-889425 | C19H18F3N3O3S | 1072921-02-8 | Details |
| Keap1-Nrf2-IN-22 | C25H22N2O6S | 2955083-85-7 | Details |
| DOCP | C43H82NO8P | 1360461-57-9 | Details |
| β-Galactosyl-C18-ceramide | C42H81NO8 | 36271-49-5 | Details |
| EpoY | C15H17NO7 | 245660-13-3 | Details |
| Fosrolapitant | C27H29F6N2O8P | 2573694-38-7 | Details |
| Pyrazophos | C14H20N3O5PS | 13457-18-6 | Details |
| BMS-986104 | C22H35NO | 1622180-31-7 | Details |
| Hinnuliquinone | C32H30N2O4 | 78860-37-4 | Details |
| PARP1-IN-31 | C22H15ClFN3O2 | 684234-60-4 | Details |
| α-Amylase-IN-9 | C13H13FN2O2S | 301359-47-7 | Details |
| Dioctanoylphosphatidic acid sodium | C19H35Na2O8P | 321883-54-9 | Details |
| PDE5-IN-8 | C22H20ClN3O2 | 1233518-60-9 | Details |
| fMIFL | C27H42N4O6S | 112275-26-0 | Details |
| Janelia Fluor 525, Haloalkan | C37H38ClF4N3O6 | 1811539-37-3 | Details |
| Anti-osteoporosis agent-11 | C23H17NO2Se2 | 2869099-50-1 | Details |
| Nispomeben | C21H27NO4 | 1443133-41-2 | Details |
| PPARδ agonist 11 | C19H15F3N2O3S2 | 2982696-04-6 | Details |
| DLCI-1 | C12H14N2S | 2244569-14-8 | Details |
| DOR agonist 2 | 1212540-02-7 | Details |
| RIPK1-IN-26 | C15H20FNO2 | 2252271-96-6 | Details |
| Fluorescein O-acrylate | C23H14O6 | 193419-86-2 | Details |
| AAZ-A 154 | C14H20N2O | 2481740-94-5 | Details |
| Sphingomyelin (d18:1/12:0) | C35H71N2O6P | 474923-21-2 | Details |
| GSK268 | Details |
| Cefamandole | C18H18N6O5S2 | 34444-01-4 | Details |
| 1-Stearoyl-sn-glycerol 3-phosphate sodium | C21H41Na2O7P | 325465-92-7 | Details |
| C.I. 37545 | C19H17NO4 | 92-73-9 | Details |
| Dehydroindapamide | C16H14ClN3O3S | 63968-75-2 | Details |
| Rp-cAMPS | C16H27N6O5PS | 73208-40-9 | Details |
| S-(-)-Aminoglutethimide D-tartrate | C17H22N2O8 | 57288-04-7 | Details |
| Cyy-272 | 2644673-01-6 | Details |
| NOD1-IN-1 | C16H14ClN3O3 | 687627-78-7 | Details |
| 15:0 PG sodium | C69H135Na2O16P | 322647-32-5 | Details |
| ALKBH5-IN-3 | C11H7F3N2O3 | 1505579-77-0 | Details |
| Phenyl(9H-purin-6-yl)amine | C11H9N5 | 1210-66-8 | Details |
| DNs-Rh | C32H18N6O15S2 | 1028386-82-4 | Details |
| Apazone dihydrate | C16H24N4O4 | 22304-30-9 | Details |
| L-368899 free base | C26H42N4O5S2 | 148927-60-0 | Details |
| GC 10284 | C15H21N2O3PS2 | 16231-76-8 | Details |
| A3AR antagonist 5 | C18H16N2O2S | 333436-43-4 | Details |
| eSM156 | Details |
| POSH-IN-2 | C22H16N2O2 | 348145-43-7 | Details |
| L 640876 | C22H21N7O3S2 | 77527-71-0 | Details |
| IL-17-IN-2 | C26H30F5N7O2 | 3058278-46-6 | Details |
| Dansyl-NECA | C30H40N8O6S | 219982-12-4 | Details |
| CDK2/4-IN-2 | C18H20F3N7O3S2 | 3034898-59-1 | Details |
| RTI-122 | C29H34FN3O3 | 3034664-39-3 | Details |
| FK-3657 | C30H27Cl2N5O4 | 167838-64-4 | Details |
| SARS-CoV-2 Mpro-IN-28 | C14H17NO3Se | 2443360-60-7 | Details |
| Remlifanserin | C24H29F2N3O2 | 2289704-13-6 | Details |
| Japonilure | C14H24O2 | 64726-91-6 | Details |
| AAZ-A 154 mesylate | C14H20N2O.CH4O3S | 2930846-03-8 | Details |
| KP-544 | C18H19ClN4O | 393856-87-6 | Details |
| JMS-175-2 | C23H19Cl4N5O3 | 3042887-70-4 | Details |
| α-Synuclein modulator 1 | C21H23N3O3 | 3058709-40-0 | Details |
| And1 degrader 1 | C26H27Cl2N3O | 3029132-46-2 | Details |
| Cartap hydrochloride | C7H16ClN3O2S2 | 15263-52-2 | Details |
| JW-65 | C18H13Cl2F3N4O2 | 2763378-71-6 | Details |
| WAY 163909 hydrochloride | C14H18N2.ClH | 428868-35-3 | Details |
| Antho-riamide I | C30H43N7O6 | 139026-54-3 | Details |
| Cismethrin | C22H26O3 | 35764-59-1 | Details |
| Antitumor agent-187 | C24H26N2O7 | 2879230-64-3 | Details |
| D-688 | 2276762-07-1 | Details |
| AC10142A | 2963581-29-3 | Details |
| SCOTfluor 510 Fmoc-Dapa-OHNew | C24H19N5O6Se | 3023933-33-4 | Details |
| CB1/2 receptor-1 | 1260669-31-5 | Details |
| AI 3-25488 | C11H4F20O | 307-70-0 | Details |
| Antifungal agent 113 | C23H20O5 | 1373311-69-3 | Details |
| KCG 1 | C13H18O2 | 139036-51-4 | Details |
| Nedemelteon | C15H18N2O2 | 1000334-38-2 | Details |
| NOX2-IN-2 diTFA | 2648709-80-0 | Details |
| KL-1156 | C17H17NO4 | 819868-62-7 | Details |
| 2-fluoro Deschloroketamine hydrochloride | C13H17ClFNO | 111982-49-1 | Details |
| Alazopeptin monohydrate | C15H22N6O6 | 1397-85-9 | Details |
| Menoctone | C24H32O3 | 14561-42-3 | Details |
| AI 3-27211 | C8H15O4PS2 | 3659-04-9 | Details |
| D4-Ribavirin | C8H10N4O3 | 131922-28-6 | Details |
| Iothalamate sodium | C11H8I3N2NaO4 | 1225-20-3 | Details |
| FTY720-C2 | C21H35NO3 | 249289-10-9 | Details |
| Gpr35 modulator 3 | C25H19FN6O2 | 3055887-18-5 | Details |
| W4275 | C25H36N6O3 | 3051650-00-8 | Details |
| Hsp110-STAT3 interaction-IN-1 | C23H31N3O4S | 882582-26-5 | Details |
| BTK-IN-38 | C27H26F2N4O2 | 2758410-51-2 | Details |
| Isoxathion | C13H16NO4PS | 18854-01-8 | Details |
| Naftypramide | C19H26N2O | 1505-95-9 | Details |
| DNA Gyrase-IN-13 | 2247443-72-5 | Details |
| Product Total： Product Page： | ||||
| 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 | ||||